TR BioSurgical Commercializes Breakthrough Tissue Repair BioScaffold

Chandler, AZ - TR BioSurgical, LLC, a veterinary biomaterials company, announced today they have commercialized a breakthrough medical device scaffold called TR Matrix. TR Matrix consists of collagen that has been engineered into a unique, open polar structure that mimics early stage connective tissue. This unique structure is a breakthrough advance in tissue repair and TR Matrix is being evaluated in a number of comparative medical applications in orthopedics, dermatology, and dentistry.

Dr. Jeff Kellerman, VP of R&D, stated, "This is a major breakthrough in tissue repair, achieved by restructuring collagen to expose natural amino acid sequences which serve as the instruction manual for tissue repair. TR Matrix's proprietary structure turns out to be critical, because during the aging process collagen becomes folded thereby hiding its natural amino acid repair code. By unfolding collagen and re-exposing these amino acid sequences, cells binding to the scaffold up-regulate a variety of important factors resulting in physiological tissue repair."

Dr. Craig Woods, CEO of TR BioSurgical stated, "Think of this like putting together a bicycle, you need an instruction manual. If the instructions are folded it makes assembly difficult. Tissue repair and assembly is no different in concept, yet much more complex. Our cells require an instruction manual to coordinate the repair process. If cells can't see the manual, then assembly and repair are suboptimal resulting in scar tissue formation. TR Matrix's open collagen structure represents an unfolded instruction manual resulting in optimal tissue repair."

SOURCE: TR BioSurgical, LLC